Haemonetics | HAE - Net Income

Stock Price
59.93
Daily Change
0.31 0.52%
Monthly
7.15%
Yearly
-4.13%
Q2 Forecast
58.65

Haemonetics reported $44.74M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Avanos Medical USD -1.3M 100K Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 672M 83M Dec/2025
Cerus USD -20.92M 17.98M Dec/2024
Cooper Companies USD 130.8M 46.2M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 327M 52.2M Dec/2025
Globus Medical USD 140.59M 21.63M Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
ICU Medical USD -15.73M 12.34M Dec/2025
Intuitive Surgical USD 821.5M 26.7M Mar/2026
Masimo USD 68.3M 168.7M Dec/2025
Medtronic USD 1.14B 231M Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Neogen USD -17M 1.08M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Quidel USD -733M 477.6M Sep/2025
ResMed USD 392.59M 44.06M Dec/2025
STAAR Surgical USD -18.31M 27.19M Dec/2025
Steris USD 192.9M 1000K Dec/2025
Stryker USD 849M 10M Dec/2025
Surmodics USD -5.32M 6.22M Jun/2025
Teleflex USD -714.33M 305.44M Dec/2025
Terumo JPY 32.65B 2.4B Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
US Physical Therapy USD 4.15M 8.98M Dec/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025